UNSPSC 85814115: Introduction of other antineoplastic into epidural space, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into epidural space, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0S305

UNSPSC 85814115, Introduction of other antineoplastic into epidural space, percutaneous approach, is a Commodity code that shows minimal alignment with actual state and local procurement activity. The recent opportunities block contains no solicitations for the medical procedure named in the code; instead, it documents widespread state and local health procurement across occupational health services, behavioral health treatment, emergency medical services, telehealth platforms, cancer screening, employee wellness programs, and community health initiatives—none of which involve antineoplastic drug delivery via epidural injection.

The issuing bodies span a broad cross-section: state health departments (Nevada Health Authority, Texas Health and Human Services Commission, Colorado Department of Human Services, New Jersey Department of Health, Illinois Secretary of State), counties (Inland Empire Health Plan in California; DeKalb, Forsyth, Cobb, and Seminole Counties; Brevard, San Mateo, Boulder, and Ventura Counties; Santa Clara and Jackson Counties; Sedgwick County and City of Wichita in Kansas; Fairfax County and Washington County; Rockland County), cities (Phoenix, Atlanta, Ocala), school districts (Parkway), health systems, and cooperative purchasing vehicles (Sourcewell, H-GAC, Region 7). The geographic spread encompasses California, Colorado, Florida, Georgia, Illinois, Kansas, Minnesota, Missouri, Nevada, New Jersey, New York, Ohio, Oregon, Texas, Virginia, and the District of Columbia. No recent opportunity in the block names this UNSPSC code or requests antineoplastic epidural delivery services. The code appears to be either misapplied in the taxonomy, rarely procured at state or local level, or absent from current market activity. Business development professionals should skip this code unless they possess specialized knowledge of rare epidural oncology service provision to state or local healthcare facilities.